CTOs on the Move

NeoGenomics Laboratories

www.neogenomics.com

 
NeoGenomics Laboratories is a prominent provider of cancer genetics testing and information services, established in 2001 and based in Fort Myers, Florida. The company specializes in a comprehensive range of oncology-focused testing, which aids healthcare professionals in diagnosing and treating cancer effectively. The services offered by NeoGenomics include advanced molecular and genetic testing for various cancers, support for clinical trials, and robust data management practices that prioritize patient data security. The company serves a diverse clientele, including pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, and managed care organizations. NeoGenomics operates multiple CAP accredited and CLIA certified laboratories across the United ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details

Similar Companies

Century 21 SGR

Century 21 SGR is a Chicago, IL-based company in the Business Services sector.

Sci Fi Channel

"SCI FI Channel is a television network where ""what if"" is what's on. SCI FI fuels the imagination of viewers with original series and events, blockbuster movies and classic science fiction and fantasy programming, as well as a dynamic Web site"

APS

APS is a Louisville, KY-based company in the Business Services sector.

EvoTekno

Evolusi Teknologi: Teknologi akan terus berevolusi dan terus berkembang. Instagram: https://t.co/f9QUMwcjOQ | Facebook: https://t.co/jzg1TVLJUt

Balt Group

Balt is a global medical device manufacturer that specializes in neurovascular and peripheral vascular interventions. Founded in 1977 by Leopold Płowiecki in Montmorency, France, the company has expanded significantly and now operates in over 100 countries with approximately 500 employees. Its U.S. subsidiary, BALT Group, is based in Irvine, California, and is recognized as a certified Great Place to Work. Balt develops a wide range of high-technology devices aimed at treating ischemic and hemorrhagic strokes, as well as peripheral embolization. The company offers the world’s broadest portfolio of neurovascular devices, including microcatheters, intracranial stents, embolization coils, flow diverters, and thrombectomy devices. Balt emphasizes research and development, holding 15 patents related to medical device design and data privacy, with a mission to enhance stroke treatment accessibility and improve patient outcomes globally.